These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32523456)

  • 21. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis.
    Flodrova P; Flodr P; Pika T; Vymetal J; Holub D; Dzubak P; Hajduch M; Scudla V
    Pathology; 2018 Apr; 50(3):261-268. PubMed ID: 29448998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist.
    Papathanasiou M; Carpinteiro A; Rischpler C; Hagenacker T; Rassaf T; Luedike P
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100519. PubMed ID: 32373710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
    Tomberli B; Cappelli F; Perfetto F; Olivotto I
    JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight.
    Logothetis CN; Fernandez J; Laber DA
    Case Rep Med; 2021; 2021():2551964. PubMed ID: 34917152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
    Puig-Carrion GD; Reyentovich A; Katz SD
    Clin Auton Res; 2019 Sep; 29(Suppl 1):45-53. PubMed ID: 31452023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report: isolated cardiac amyloidosis: an enigma unravelled.
    Khalid U; Awar O; Verstovsek G; Cheong B; Yellapragada SV; Jneid H; Deswal A; Virani SS
    Methodist Debakey Cardiovasc J; 2015; 11(1):53-8. PubMed ID: 25793032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac amyloidosis.
    Martinez-Naharro A; Hawkins PN; Fontana M
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s30-s35. PubMed ID: 29700090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
    Yamamoto H; Yokochi T
    ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the Treatment of Cardiac Amyloidosis.
    Macedo AVS; Schwartzmann PV; de Gusmão BM; Melo MDT; Coelho-Filho OR
    Curr Treat Options Oncol; 2020 Apr; 21(5):36. PubMed ID: 32328845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
    Carr AS; Pelayo-Negro AL; Jaunmuktane Z; Scalco RS; Hutt D; Evans MR; Heally E; Brandner S; Holton J; Blake J; Whelan CJ; Wechalekar AD; Gillmore JD; Hawkins PN; Reilly MM
    Neuromuscul Disord; 2015 Jun; 25(6):511-5. PubMed ID: 25819286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E; López-Sainz Á; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac Amyloidosis: Diagnosis and Treatment Strategies.
    Tuzovic M; Yang EH; Baas AS; Depasquale EC; Deng MC; Cruz D; Vorobiof G
    Curr Oncol Rep; 2017 Jul; 19(7):46. PubMed ID: 28528458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Amyloidosis Detected on Imaging of Patients with Heart Failure.
    Roginić S; Vinter O; Trbušić M; Roginić M; Ćatić Ćuti E
    Am J Case Rep; 2020 Nov; 21():e926290. PubMed ID: 33175723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case Report and Literature Review of Cardiac Amyloidosis: A Not-So-Rare Cause of Heart Failure.
    Baptista P; Moura de Azevedo S; Alexandre A; Dias-Frias A
    Cureus; 2023 Jan; 15(1):e33364. PubMed ID: 36751253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.
    Gopal DM; Ruberg FL; Siddiqi OK
    Curr Heart Fail Rep; 2019 Oct; 16(5):180-188. PubMed ID: 31520266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac amyloidosis: A case report and review of literature.
    Taiwo AA; Alapati L; Movahed A
    World J Clin Cases; 2019 Mar; 7(6):742-752. PubMed ID: 30968039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.